West VirginiaRelating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Mar 27To Health and Human ResourcesLatest
- Mar 27To Health and Human ResourcesMinor
- Mar 27Introduced in SenateMinor
- Mar 26Communicated to Senate
- Vote recorded PASSAGE. Result: pass.Lower
- Mar 26Title amendment adopted (Voice vote)
- Mar 26Passed House (Roll No. 197)Passed House
- Mar 26Read 3rd timeMinor
- Mar 26On 3rd reading, Special Calendar
- Mar 25Amendment rejected (Voice vote)Minor
- Mar 25Amendment reported by the Clerk
- Mar 25Amendment adopted (Voice vote)
- Mar 25Amendment reported by the Clerk
- Mar 25Read 2nd timeMinor
- Mar 25On 2nd reading, Special Calendar
- Mar 24Read 1st timeMinor
- Mar 24On 1st reading, Special Calendar
- Mar 21By substitute, do pass
- Mar 18Markup Discussion
- Mar 13To House Health and Human ResourcesMinor
- Mar 13Introduced in HouseMinor
- Mar 13To Health and Human ResourcesMinor
- Mar 13Filed for introductionIntroduced